Upstream Bio UPB
NASDAQ UPB
$2.74 -0.25 (-8.36%)
At close: Oct 23, 2026 · 4:00 PM EDT

Upstream Bio (UPB) Sale and Maturity of Investments (2023 - 2026)

Updated

Analysis

Upstream Bio (UPB) Sale and Maturity of Investments (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Upstream Bio 150.07 Mn -1.12 Bn -3.29 Mn 66.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 66.70 Mn
Mar 31, 2026 56.82 Mn
Dec 31, 2025 97.28 Mn
Sep 30, 2025 72.71 Mn
Jun 30, 2025 69.90 Mn
Mar 31, 2025 52.68 Mn
Dec 31, 2024 84.30 Mn
Sep 30, 2024 75.14 Mn
Jun 30, 2024 34.93 Mn
Mar 31, 2024 37.26 Mn
Dec 31, 2023 29.55 Mn
API Access

Upstream Bio Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=UPB&period=max&api_key=YOUR_API_KEY